Early Warning System for Allergic Rhinitis in the MASK-air® App
ConditionAllergic Rhinitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidade do Porto
About this trial
The primary objective consists in the comparison of the combined symptom medication score values between (i) patients randomised to the early warning system personalised forecasting messages, and (ii) patients randomised to generic messages already delivered by MASK-air®.
The combined symptom medication score has recently been developed in a data-driven way and validated (https://eaaci.org/images/CSMS.pdf); it assesses allergic rhinitis control taking into account both reported symptoms and medication use.
As secondary objectives, visual analogue scales on allergic rhinitis symptoms (VAS global, nasal, eye, asthma), and medication use will also be separately compared.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Illiterate patients
Patients without smartphone
Patients who are not able to complete a daily monitoring questionnaire on allergic rhinitis.
Trial design
Design model
Parallel
Treatments tested in this trial
Personalised early warning system
Combination productEarly warning system personalised forecasting messages
Treatment groups
210 Participants
are divided into 2 treatment groupsGroup A: Generic messages already delivered by MASK-air®No intervention 0 interventions
Group B: Early warning system personalised forecasting messagesExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Combined symptom medication score values
Daily symptom and medication data provided by patients allow the calculation of two validated daily combined symptom-medication scores from formulae previously published: * the CSMS (combined symptom-medication score) * e-DASTHMA.
Time frame
From enrollment to the end of intervention at 2 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidade do Porto
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: